Clinical stage biopharma small-cap, Harpoon Therapeutics has entered the spotlight with pharma giant, Merck agreeing to acquire the company for a staggering $680 million.

December's Consumer Price Index (CPI) data is in, and it brought a mixed bag of news for investors and consumers alike. While headline inflation ticked up slightly to 3.4%, exceeding most analysts' expectations, the core inflation rate held steady at 3.9%.

The first-ever U.S. spot bitcoin ETFs began trading on Thursday, January 11th, 2024, marking a long-awaited milestone for the cryptocurrency industry and sparking a frenzy of excitement as well as apprehension among investors.

In a groundbreaking move, pharmaceutical giant Johnson & Johnson has set the stage for a significant leap forward in cancer treatment with its recent $2 billion acquisition of Ambrx Biopharma.

Customer experience player, TDCX has been recently buzzing on social media as its shares experienced a staggering surge following an acquisition proposal from the company's CEO, Laurent Junique.

Amidst Wayfair's recent struggles, two Chinese e-commerce giants, Shein and Temu, are emerging as potential acquirers, as per recent speculations.

3D printing player, Stratasys finds itself at the center of attention as Nano Dimension makes a renewed takeover offer of $16.50 per share.